We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

PTK787 in Refractory or Relapsed Diffuse Large Cell Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00511043
Recruitment Status : Terminated (Manufacturer stopped drug development)
First Posted : August 3, 2007
Last Update Posted : December 9, 2014
Novartis Pharmaceuticals
Information provided by (Responsible Party):
David Rizzieri, MD, Duke University Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : August 2009
  Study Completion Date : June 2010
  Certification or Request for Extension to Delay Results Submission: September 7, 2012